期刊
NUTRIENTS
卷 15, 期 18, 页码 -出版社
MDPI
DOI: 10.3390/nu15183960
关键词
ghrelin; depression; metabolic syndrome; obesity; microbiota
This review article introduces the relationship between the appetite hormone ghrelin and disorders such as depression and metabolic syndrome, as well as its role in regulating inflammation, cardiac function, stress, and anxiety. It also evaluates the potential of the ghrelinergic system as a target for pharmacotherapy development.
Ghrelin, a gastrointestinal peptide, is an endogenous ligand of growth hormone secretagogue receptor 1a (GHSR1a), which is mainly produced by X/A-like cells in the intestinal mucosa. Beyond its initial description as a growth hormone (GH) secretagogue stimulator of appetite, ghrelin has been revealed to have a wide range of physiological effects, for example, the modulation of inflammation; the improvement of cardiac performance; the modulation of stress, anxiety, taste sensation, and reward-seeking behavior; and the regulation of glucose metabolism and thermogenesis. Ghrelin secretion is altered in depressive disorders and metabolic syndrome, which frequently co-occur, but it is still unknown how these modifications relate to the physiopathology of these disorders. This review highlights the increasing amount of research establishing the close relationship between ghrelin, nutrition, microbiota, and disorders such as depression and metabolic syndrome, and it evaluates the ghrelinergic system as a potential target for the development of effective pharmacotherapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据